191 related articles for article (PubMed ID: 32033928)
1. Prognostic Significance of bcr-1 and bcr-3 Isoforms of PML-RARA and FLT3-ITD in Patients With Acute Promyelocytic Leukemia.
Rasekh EO; Elsayed GM; Madney Y; El Gammal MM
Clin Lymphoma Myeloma Leuk; 2020 Mar; 20(3):156-167. PubMed ID: 32033928
[TBL] [Abstract][Full Text] [Related]
2. [Prevalence and clinical significance of FLT3 mutations in acute promyelocytic leukemia].
Xue MX; Qiu HY; Feng YF; Zhu ZL; Chang WR; Liang JY; Chen SN; Cen JN; Xue YQ; Liu YJ; Sun AN; Wu DP
Zhonghua Xue Ye Xue Za Zhi; 2008 Nov; 29(11):757-61. PubMed ID: 19176014
[TBL] [Abstract][Full Text] [Related]
3. Internal tandem duplication of the FLT3 gene confers poor overall survival in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline-based chemotherapy: an International Consortium on Acute Promyelocytic Leukemia study.
Lucena-Araujo AR; Kim HT; Jacomo RH; Melo RA; Bittencourt R; Pasquini R; Pagnano K; Fagundes EM; Chauffaille Mde L; Chiattone CS; Lima AS; Ruiz-Argüelles G; Undurraga MS; Martinez L; Kwaan HC; Gallagher R; Niemeyer CM; Schrier SL; Tallman MS; Grimwade D; Ganser A; Berliner N; Ribeiro RC; Lo-Coco F; Löwenberg B; Sanz MA; Rego EM
Ann Hematol; 2014 Dec; 93(12):2001-10. PubMed ID: 24981688
[TBL] [Abstract][Full Text] [Related]
4. All-trans Retinoic Acid, Arsenic Trioxide, and Anthracycline-based Chemotherapy Improves Outcome in Newly Diagnosed Acute Promyelocytic Leukemia Regardless of FLT3-ITD Mutation Status.
Xu LW; Su YZ; Tao HF
Curr Med Sci; 2021 Jun; 41(3):491-497. PubMed ID: 34169421
[TBL] [Abstract][Full Text] [Related]
5. Internal tandem duplication and Asp835 mutations of the FMS-like tyrosine kinase 3 (FLT3) gene in acute promyelocytic leukemia.
Shih LY; Kuo MC; Liang DC; Huang CF; Lin TL; Wu JH; Wang PN; Dunn P; Lai CL
Cancer; 2003 Sep; 98(6):1206-16. PubMed ID: 12973844
[TBL] [Abstract][Full Text] [Related]
6. Prognostic implication of FLT3 and Ras gene mutations in patients with acute promyelocytic leukemia (APL): a retrospective study from the European APL Group.
Callens C; Chevret S; Cayuela JM; Cassinat B; Raffoux E; de Botton S; Thomas X; Guerci A; Fegueux N; Pigneux A; Stoppa AM; Lamy T; Rigal-Huguet F; Vekhoff A; Meyer-Monard S; Ferrand A; Sanz M; Chomienne C; Fenaux P; Dombret H;
Leukemia; 2005 Jul; 19(7):1153-60. PubMed ID: 15889156
[TBL] [Abstract][Full Text] [Related]
7. 'FLT3-ITD Mutation Does Not Influence Survival Outcome in Adult Acute Promyelocytic Leukemia Patients Treated With ATO and ATRA-Based Therapeutic Regimen: Experience From a North Indian Tertiary Care Centre'.
Deka RR; Naseem S; Bhatia P; Binota J; Sonam P; Rana P; Malhotra P; Varma N
Clin Lymphoma Myeloma Leuk; 2022 Jun; 22(6):416-423. PubMed ID: 34987015
[TBL] [Abstract][Full Text] [Related]
8. Relationship between FLT3 mutation status, biologic characteristics, and response to targeted therapy in acute promyelocytic leukemia.
Gale RE; Hills R; Pizzey AR; Kottaridis PD; Swirsky D; Gilkes AF; Nugent E; Mills KI; Wheatley K; Solomon E; Burnett AK; Linch DC; Grimwade D;
Blood; 2005 Dec; 106(12):3768-76. PubMed ID: 16105978
[TBL] [Abstract][Full Text] [Related]
9. Cytogenetic and FMS-like tyrosine kinase 3 mutation analyses in acute promyelocytic leukemia patients.
Yaghmaie M; Alimoghaddam K; Mozdarani H; Ghavamzadeh A; Hajhashemi M; Aznab M; Ghaffari SH
Iran Biomed J; 2012; 16(1):10-7. PubMed ID: 22562027
[TBL] [Abstract][Full Text] [Related]
10. Influence of bcr-3 PML-RARα transcript on outcome in Acute Promyelocytic Leukemia patients of Kashmir treated with all-trans retinoic acid and/or arsenic tri-oxide.
Baba SM; Shah ZA; Pandith AA; Dil-Afroze ; Jan A; Mir KA; Aziz SA; Ahmad Z
Cancer Genet; 2019 Feb; 231-232():14-21. PubMed ID: 30803552
[TBL] [Abstract][Full Text] [Related]
11. Long FLT3 internal tandem duplications and reduced PML-RARα expression at diagnosis characterize a high-risk subgroup of acute promyelocytic leukemia patients.
Chillón MC; Santamaría C; García-Sanz R; Balanzategui A; Sarasquete ME; Alcoceba M; Marín L; Caballero MD; Vidriales MB; Ramos F; Bernal T; Díaz-Mediavilla J; García de Coca A; Peñarrubia MJ; Queizán JA; Giraldo P; San Miguel JF; González M
Haematologica; 2010 May; 95(5):745-51. PubMed ID: 20133893
[TBL] [Abstract][Full Text] [Related]
12. Inferior prognostic outcome in acute promyelocytic leukemia with alterations of FLT3 gene.
Yoo SJ; Park CJ; Jang S; Seo EJ; Lee KH; Chi HS
Leuk Lymphoma; 2006 Sep; 47(9):1788-93. PubMed ID: 17064989
[TBL] [Abstract][Full Text] [Related]
13. No prognostic significance of normalized copy number of PML-RARA transcript at diagnosis in patients with acute promyelocytic leukemia.
Rasekh EO; Elsayed GM; Fathy S
Hematol Oncol Stem Cell Ther; 2021 Jun; 14(2):119-125. PubMed ID: 32735792
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of FLT3 internal tandem duplication and tyrosine kinase domain mutations in acute promyelocytic leukemia: a systematic review.
Beitinjaneh A; Jang S; Roukoz H; Majhail NS
Leuk Res; 2010 Jul; 34(7):831-6. PubMed ID: 20096459
[TBL] [Abstract][Full Text] [Related]
15. [FLT3 internal tandem duplication in patients with acute promyelocytic leukemia].
Zhu YM; Liu YF; Zhang SJ; Shen ZX; Hu J
Zhonghua Xue Ye Xue Za Zhi; 2007 Jun; 28(6):371-4. PubMed ID: 17939400
[TBL] [Abstract][Full Text] [Related]
16. Arsenic trioxide in front-line therapy of acute promyelocytic leukemia (C9710): prognostic significance of FLT3 mutations and complex karyotype.
Poiré X; Moser BK; Gallagher RE; Laumann K; Bloomfield CD; Powell BL; Koval G; Gulati K; Holowka N; Larson RA; Tallman MS; Appelbaum FR; Sher D; Willman C; Paietta E; Stock W
Leuk Lymphoma; 2014 Jul; 55(7):1523-32. PubMed ID: 24160850
[TBL] [Abstract][Full Text] [Related]
17. Clinical impact of FLT3 mutation load in acute promyelocytic leukemia with t(15;17)/PML-RARA.
Schnittger S; Bacher U; Haferlach C; Kern W; Alpermann T; Haferlach T
Haematologica; 2011 Dec; 96(12):1799-807. PubMed ID: 21859732
[TBL] [Abstract][Full Text] [Related]
18.
Esnault C; Rahmé R; Rice KL; Berthier C; Gaillard C; Quentin S; Maubert AL; Kogan S; de Thé H
Blood; 2019 Mar; 133(13):1495-1506. PubMed ID: 30674471
[TBL] [Abstract][Full Text] [Related]
19. FLT3 mutation status is a predictor of early death in pediatric acute promyelocytic leukemia: a report from the Children's Oncology Group.
Kutny MA; Moser BK; Laumann K; Feusner JH; Gamis A; Gregory J; Larson RA; Powell BL; Stock W; Willman CL; Woods WG; Meshinchi S
Pediatr Blood Cancer; 2012 Oct; 59(4):662-7. PubMed ID: 22378655
[TBL] [Abstract][Full Text] [Related]
20. Prognostic factors of patients with newly diagnosed acute promyelocytic leukemia treated with arsenic trioxide-based frontline therapy.
Lou Y; Ma Y; Suo S; Ni W; Wang Y; Pan H; Tong H; Qian W; Meng H; Mai W; Huang J; Yu W; Wei J; Mao L; Jin J
Leuk Res; 2015 Sep; 39(9):938-44. PubMed ID: 26183877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
